Debaryomyces hansenii (Saccharomycetaceae) Salt-Tolerant Yeast, Mycocandida

Debaryomyces hansenii is a remarkable halotolerant yeast species, widely recognized as a safe probiotic, a key player in food fermentation, and a promising biocontrol agent. It is most notably used in aquaculture to enhance growth, modulate gut microbiota, and improve immune function. The yeast produces valuable bioactive compounds including β-glucans, polyamines, and killer toxins, contributing to its immunostimulatory, antimicrobial, and antifungal activities. Recent research has elucidated its sophisticated stress adaptation mechanisms and validated its safety and efficacy as a probiotic for both terrestrial and aquatic animals.

---

1. Taxonomic Insights

Species: Debaryomyces hansenii (Zopf) Lodder & Kreger-van Rij

Family: Saccharomycetaceae

The Saccharomycetaceae family comprises the true yeasts, characterized by their unicellular growth form and ascomycetous reproduction. This family includes some of the most industrially and medically significant yeast species. Debaryomyces hansenii is classified within the order Saccharomycetales, subphylum Saccharomycotina, phylum Ascomycota.

Taxonomic Note: The species was originally described as Saccharomyces hansenii by Wilhelm Zopf in 1890. It was later reclassified into the genus Debaryomyces. The species has approximately 70 synonyms, including Candida famata and Torulaspora hansenii. The Debaryomyces hansenii species complex shows significant genetic diversity, with two varieties distinguished: D. hansenii var. hansenii and D. hansenii var. fabryi. Genomic analyses have revealed that some strains previously classified as D. hansenii may represent distinct species, including Debaryomyces tyrocola, forming a species complex.

Related Species from the Same Family:

· Saccharomyces cerevisiae (Baker‘s/Brewer’s Yeast): The most well-known yeast species, used in baking, brewing, and as a probiotic, sharing similar immunomodulatory properties through β-glucan content.

· Debaryomyces hansenii var. fabryi: A variety with distinct physiological properties, including different maximum growth temperatures and enzymatic profiles.

· Debaryomyces tyrocola: A recently distinguished cryptic species within the D. hansenii complex, associated with cheese ripening.

· Candida famata: A taxonomic synonym that still appears in clinical and food microbiology literature, representing the anamorphic state.

---

2. Common Names

Scientific Name: Debaryomyces hansenii | English: Salt-Tolerant Yeast, Mycocandida | Spanish/Portuguese: Levadura halotolerante | French: Levure halotolérante | German: Salzliebende Hefe | Korean: 간장 효모 (Ganjang Hyomo - referring to its role in soy sauce fermentation) | Japanese: 耐塩性酵母 (Taienshitsu kōbo) | Chinese: 汉逊德巴利酵母 (Hanxun Debali Jiaomu) |

---

3. Medicinal Uses

Primary Actions: Immunomodulatory, Probiotic, Antimicrobial, Antifungal (biocontrol), Antioxidant, Growth promoter.

Secondary Actions: Anti-inflammatory (IL-10 induction), Prebiotic (via β-glucans), Gastroprotective, Metabolic modulator, Stress-protective (osmo- and cryo-protective).

Medicinal Parts:

The whole yeast cells (live or heat-inactivated) and extracted bioactive compounds are used for therapeutic purposes.

· Whole Yeast Cells (Live): The primary form used as a probiotic in animal feed and aquaculture. Live cells colonize the gut and provide immunostimulatory benefits.

· Whole Yeast Cells (Heat-Inactivated): Used as a postbiotic, providing immunomodulatory benefits without the risks associated with live administration.

· β-Glucans: Polysaccharides extracted from the yeast cell wall, containing (1-6)-branched (1-3)-β-D-glucan structures, used for immunostimulation and antioxidant effects.

· Cell Wall Components (Mannoproteins, Chitin): Contribute to the immunomodulatory properties of the yeast.

· Polyamines (Spermidine, Spermine): Intracellular compounds that play crucial roles in cell proliferation and differentiation.

· Killer Toxins (Mycocins): Excreted proteins with antimicrobial activity against competing yeast species.

---

4. Phytochemicals Specific to the Plant and Their Action

· β-Glucans (Structural): The cell wall contains (1-6)-branched (1-3)-β-D-glucans as the predominant glucan type. These polysaccharides are potent Immunomodulators, activating immune cells through dectin-1 and TLR4 receptors, increasing phagocytic activity, and promoting reactive oxygen species and nitric oxide production. They also exhibit Antioxidant activities by enhancing superoxide dismutase and catalase enzymes.

· Polyamines (Spermidine, Spermine): Intracellular compounds with Cell-proliferative and Differentiation-promoting properties. They play essential roles in gut development, immune function, and cellular stress responses.

· Killer Toxins (Mycocins): Protein compounds excreted by some strains, exhibiting Antifungal activity against pathogenic Candida species and other competing yeasts. These toxins disrupt the cell membranes of sensitive fungi.

· Enzymes (β-1,3-Glucanase, Chitinase, Protease, Lipase): Secreted enzymes with Antifungal mechanisms, capable of degrading fungal cell walls. β-1,3-glucanase and chitinase specifically target components of phytopathogenic fungi. Proteases and lipases contribute to flavor development in fermented foods.

· Volatile Flavor Compounds (Branched-chain Aldehydes, Alcohols, 4-Vinylguaiacol): Produced through various metabolic pathways including ferulic acid decarboxylation, amino acid Ehrlich conversion, and protein-lipid hydrolysis. These compounds contribute to the Aromatic profiles of fermented products and may have additional biological activities.

· Superoxide Dismutase (SOD): An antioxidant enzyme with high specific activity in some strains, contributing to Oxidative stress resistance and potential therapeutic applications.

· Glycerol: Accumulated intracellularly as a Osmoprotectant under high salinity conditions, allowing survival in environments with up to 20-24% NaCl.

· Arabitol: A sugar alcohol produced via the pentose phosphate pathway, contributing to Osmotolerance and potentially serving as a prebiotic compound.

---

5. Traditional and Ethnobotanical Uses

Debaryomyces hansenii has no traditional medicinal use in classical herbal systems, as it is a microscopic yeast rather than a plant. However, it has a long history of safe use in food fermentation, which has led to its modern recognition as a probiotic and biotherapeutic agent.

Food Fermentation (Traditional Food Use)

Formulation: Naturally occurring yeast in fermented foods.

Description: D. hansenii is a dominant yeast species in a wide range of fermented foods. It is found in all types of cheeses, including soft, semi-hard, and hard cheeses, where it contributes to ripening and flavor development. It is also abundant in sausages, dry-meat products, and Korean fermented soy sauce (ganjang). In these contexts, it has been consumed safely by humans for centuries.

Reasoning: The yeast's halotolerance allows it to thrive in the high-salt environments of cheese brines and soy sauce fermentation. Its metabolic activities produce desirable volatile compounds and contribute to product preservation.

Probiotic for Animal Health (Modern Application)

Formulation: Live yeast cells incorporated into animal feed.

Preparation & Use: D. hansenii is administered orally as a feed supplement for terrestrial animals (goats, mice) and aquatic animals (fish, shrimp). Typical doses vary by species and application.

Reasoning: The yeast has Qualified Presumption of Safety status from the European Food Safety Authority. Its probiotic effects include immunostimulation, gut microbiota modulation, enhanced cell proliferation and differentiation, and improved digestive function. The immunomodulatory effects are mediated through β-glucans and polyamines.

Biocontrol Agent (Post-Harvest Preservation)

Formulation: Live yeast cell suspension applied to fruits.

Preparation & Use: Antarctic strains of D. hansenii have been evaluated for controlling post-harvest fungal pathogens on strawberries. The yeast is applied as a spray or dip to inhibit the growth of Botrytis cinerea and Rhizopus stolonifer.

Reasoning: The yeast produces antifungal enzymes (β-1,3-glucanase, chitinase, protease) that degrade fungal cell walls. It also competes with pathogens for nutrients and space, and resists oxidative stress in the wound environment.

---

6. Healing Recipes and Preparations

As a probiotic microorganism, D. hansenii is not prepared in traditional herbal formulas. Instead, it is incorporated into food products or formulated as a feed supplement.

Probiotic Feed Supplement for Aquaculture

Purpose: To enhance growth, immune function, and disease resistance in farmed fish.

Preparation & Use:

1. D. hansenii is cultured under controlled conditions to produce a concentrated biomass.

2. The yeast is then incorporated into fish feed at concentrations ranging from 1.1% to 2.2% of the diet, corresponding to approximately 1.7 to 3.6 x 10⁶ CFU per gram of feed.

3. The supplemented feed is administered to fish for periods of 4-10 weeks to observe growth and immune benefits.

β-Glucan Extract for Immunostimulation

Purpose: Isolated β-glucans for immune enhancement in animals.

Preparation & Use:

1. D. hansenii biomass is subjected to alkaline and acid extraction to isolate cell wall β-glucans.

2. The extracted glucans are then incorporated into cell culture media or administered to animals.

3. In research settings, β-glucans from D. hansenii have been shown to activate leukocytes, increase phagocytic activity, and enhance antioxidant enzyme production.

Fermented Food Starter Culture

Purpose: To improve flavor, safety, and preservation of fermented products.

Preparation & Use:

1. D. hansenii strains are selected for their specific metabolic properties (e.g., protease activity, flavor production).

2. The yeast is inoculated into food matrices such as sausages, cheeses, or soy sauce fermentations.

3. The fermentation proceeds under controlled conditions, allowing the yeast to produce desirable volatile compounds and inhibit spoilage organisms.

---

7. In-Depth Phytochemical Profile and Clinical Significance of Debaryomyces hansenii

Introduction

Debaryomyces hansenii represents a remarkable convergence of probiotic science, food biotechnology, and extremophile biology. Unlike medicinal plants, this unicellular yeast is not visible to the naked eye, yet its therapeutic and industrial impact is immense. As a halotolerant, psychrotolerant, and xerotolerant organism, D. hansenii thrives in environments that would destroy most other microbes, from the salt-saturated brines of cheese production to the cold waters of the Antarctic. This extraordinary stress tolerance, combined with a long history of safe use in food, has positioned it as a leading candidate for probiotic development in both terrestrial and aquatic animals. Modern research has dissected its mechanisms of action at the molecular level, identifying specific cell wall components, intracellular polyamines, and secreted enzymes that mediate its beneficial effects. Recent transcriptomic and genomic studies have further elucidated its interactions with host tissues, revealing a sophisticated ability to modulate immune responses while maintaining homeostatic balance. D. hansenii stands as a paradigm of the next-generation probiotic, offering validated benefits for growth, immunity, and disease resistance.

1. β-Glucans: The Signature Immunomodulatory Cell Wall Component

Key Compounds: (1-6)-branched (1-3)-β-D-glucans.

Quantitative Profile: β-glucans constitute approximately 50-60% of the yeast cell wall. The yield of extracted glucans from dried yeast biomass ranges from 6.6% to 11% depending on the strain and extraction method. Structural characterization by proton nuclear magnetic resonance confirms the presence of (1-6)-branched (1-3)-β-D-glucan, a structure known for potent immunostimulatory activity.

Actions and Clinical Relevance:

· Immunomodulation (Clinically Validated Mechanism): β-Glucans derived from D. hansenii are potent activators of the innate immune system. In vitro studies using goat peripheral blood leukocytes have demonstrated that these β-glucans significantly increase cell immune parameters, including phagocytic ability, reactive oxygen species production (respiratory burst), peroxidase activity, and nitric oxide production. These are all critical mechanisms for eliminating pathogens.

· Antioxidant Enhancement: Beyond direct immune activation, D. hansenii-derived β-glucans enhance the host's antioxidant defenses. Studies have shown increased superoxide dismutase and catalase activities in leukocytes stimulated with yeast β-glucans. This dual effect of boosting both immune and antioxidant capacity is particularly valuable for protecting animals from oxidative stress during infection or inflammation.

· Receptor-Mediated Activation: The immunostimulatory effects of β-glucans are mediated through specific recognition receptors. Research has confirmed that β-glucans from D. hansenii are able to activate dectin-1 mRNA gene expression, the primary receptor for β-glucans. Additionally, TLR4 gene expression is up-regulated in leukocytes after stimulation. This receptor activation triggers downstream signaling cascades that lead to the observed functional changes.

· Safety and Non-Toxicity: Comprehensive in vitro assessments have confirmed that D. hansenii-derived β-glucans are non-toxic and safe molecules for mammalian leukocytes, showing no adverse effects on cell viability at effective concentrations.

2. Polyamines: The Cell Proliferation and Differentiation Factors

Key Compounds: Spermidine, Spermine.

Actions and Clinical Relevance:

· Gut Development and Health: D. hansenii strains are especially rich producers of spermidine and spermine, molecules that play crucial roles in cell proliferation and differentiation. This property is particularly relevant for gut health, where rapid cell turnover is essential for maintaining barrier function and nutrient absorption. Oral delivery of D. hansenii has been associated with enhanced cell proliferation and differentiation in the intestinal epithelium.

· Immune Function: Polyamines also contribute to immune modulation, influencing lymphocyte activation and function. The presence of these compounds in D. hansenii adds another layer to its probiotic benefits, complementing the effects of β-glucans.

3. Killer Toxins (Mycocins): The Antimicrobial Arsenal

Key Compounds: Proteinaceous killer toxins with molecular weights ranging from 10-20 kDa.

Actions and Clinical Relevance:

· Antifungal Activity Against Pathogenic Candida: Food-derived D. hansenii strains produce killer toxins effective against pathogenic Candida yeasts, including Candida albicans. This activity is of significant clinical interest, as Candida infections are common in immunocompromised individuals. The toxins work by disrupting the cell membrane of sensitive fungi, leading to cell death.

· Biocontrol in Food Systems: In food fermentation, killer toxin production by D. hansenii helps control spoilage yeasts and molds, contributing to product preservation without the need for chemical preservatives. This is particularly relevant for clean-label food production.

4. Enzymatic Arsenal: β-1,3-Glucanase, Chitinase, and Proteases

Key Compounds: β-1,3-glucanase, chitinase, protease, lipase.

Actions and Clinical Relevance:

· Biocontrol Mechanisms Against Phytopathogenic Fungi: Research on the Antarctic yeast strain D. hansenii UFT8244 has elucidated its biocontrol mechanisms against the post-harvest fungal pathogens Botrytis cinerea (gray mold) and Rhizopus stolonifer. The yeast produces β-1,3-glucanase, chitinase, and protease in the presence of fungal cell walls. β-1,3-glucanase activity peaks on day 12 of incubation and remains high until day 15, while chitinase and protease activities reach their highest levels on day 15. These enzymes degrade the structural components of fungal cell walls, leading to hyphal damage and growth inhibition.

· Spore Germination Inhibition: D. hansenii strongly inhibits the germination of B. cinerea spores, with the strongest inhibition (57%) observed at 0°C, followed by 40% at 25°C. The yeast also surrounds and colonizes the germ tubes and hyphae of the pathogen, physically preventing its spread. This cold-active property makes it particularly suitable for post-harvest preservation of refrigerated fruits.

· Oxidative Stress Resistance: D. hansenii demonstrates the ability to resist oxidative stress, which is crucial for survival in the wound environment of fruits and for competing with pathogens. This resistance ensures the yeast remains viable and effective during application.

5. Probiotic Effects in Aquaculture: A Systems-Level Understanding

Growth Promotion and Feed Efficiency: In juvenile gilthead seabream, dietary administration of D. hansenii at 1.1% of the diet for 70 days resulted in a 12% increase in somatic growth and improved feed conversion ratio compared to control fish. This growth enhancement is attributed to improved digestive function and nutrient absorption, mediated by the yeast's effects on gut health.

Gut Microbiota Modulation: Probiotic D. hansenii modulates the gut microbiota without causing dysbiosis. Changes in microbiota are characterized by a reduction in the abundance of several groups of Proteobacteria, especially those characterized as opportunistic groups. This selective modulation of the microbial community supports host health by reducing competition for nutrients and eliminating potential pathogens.

Intestinal Condition Improvement: Transcriptomic analysis of the anterior-mid intestine revealed 232 differentially expressed genes in fish fed D. hansenii-supplemented diets. These genes are mostly related to metabolic pathways (particularly protein-related, sphingolipid, and thymidylate pathways), antioxidant mechanisms, immune processes, and symbiotic interactions. The yeast also increases the staining intensity of mucins rich in carboxylated and weakly sulphated glycoconjugates in goblet cells, indicating enhanced mucus production and gut barrier function.

Safety Confirmation: Importantly, D. hansenii administration does not alter intestinal cell organization nor generate dysbiosis, demonstrating its safety as a feed additive. The yeast stimulates host-microbiota interactions while maintaining homeostatic status.

6. Skin and Mucosal Immunity: Extending Benefits Beyond the Gut

Skin Barrier Enhancement: Dietary D. hansenii promotes skin barrier function through the up-regulation of anchoring junction genes. A total of 23 differentially expressed genes related to anchoring junctions were identified, reinforcing the physical defense against potential skin damage. This is critical for fish, whose skin is the primary interface with the aquatic environment.

Immune Modulation in Skin: D. hansenii administration induces a strong modulation of immune biological processes in the skin, involving 61 differentially expressed genes primarily related to B- and T-cell regulatory pathways. This indicates that the probiotic's effects are systemic, not limited to the gut.

Increased Mucus Defensive Capacity: The modulated functioning of skin cells leads to increased exudation of innate immune components into the mucus. In vitro co-culture trials with pathogenic bacteria demonstrated that mucus from D. hansenii-fed fish has enhanced defensive capacity. This is of great practical significance for disease prevention in aquaculture.

7. Stress Tolerance Mechanisms: The Molecular Basis of Extremophily

Halotolerance: The most distinguishing feature of D. hansenii is its ability to grow in the presence of extremely high salt concentrations (up to 20-24% NaCl). The molecular basis of salt tolerance has been extensively studied and is linked to the yeast's ability to accumulate high intracellular concentrations of glycerol as a compatible solute. The High Osmolarity Glycerol (HOG)-MAPK pathway plays a crucial role in facilitating this glycerol accumulation.

Metabolic Adaptations: D. hansenii metabolizes sugars to pyruvate via the Embden-Meyerhof-Parnas (EMP) pathway, followed by oxidation in the tricarboxylic acid cycle. It can assimilate organic acids including citric, lactic, and succinic acids. The pentose phosphate pathway also operates, producing arabitol. Under salt stress, the yeast modulates carbon and nitrogen metabolic fluxes, activating antioxidant defense systems bidirectionally.

Cryotolerance and Psychrophilic Adaptation: Antarctic strains of D. hansenii have adapted to cold environments, maintaining metabolic activity and biocontrol efficacy at temperatures as low as 0°C. This property is rare among yeasts and has significant biotechnological applications.

An Integrated View of Healing and Application in Debaryomyces hansenii

· As a Probiotic for Aquaculture and Terrestrial Animals: D. hansenii functions as a comprehensive probiotic through multiple, integrated mechanisms. First, direct immunostimulation: Cell wall β-glucans activate innate immune cells via dectin-1 and TLR4 receptors, enhancing phagocytosis and pathogen killing. Second, gut health promotion: Polyamines support intestinal epithelial cell proliferation and differentiation, maintaining barrier integrity and nutrient absorption. Third, microbiota modulation: The yeast reduces opportunistic Proteobacteria while supporting beneficial commensals, creating a gut environment resistant to pathogen colonization. Fourth, systemic effects: Transcriptomic evidence shows immune modulation extends to distal sites like the skin, enhancing overall host defense. Fifth, growth promotion: Improved feed conversion and nutrient absorption translate to measurable increases in somatic growth. This multi-pronged mechanism, validated through histological, transcriptomic, and functional studies, makes D. hansenii a leading probiotic candidate for sustainable animal production.

· As a Biocontrol Agent for Post-Harvest Preservation: D. hansenii offers an effective, environmentally friendly alternative to chemical fungicides. First, direct enzymatic attack: The yeast secretes β-1,3-glucanase and chitinase, enzymes that degrade fungal cell walls, causing hyphal damage and growth inhibition. Second, competitive exclusion: The yeast rapidly colonizes wound sites, outcompeting pathogens for nutrients and space. Third, spore germination inhibition: D. hansenii directly inhibits the germination of fungal spores, preventing infection establishment. Fourth, cold-active efficacy: Unlike many biocontrol agents, Antarctic strains maintain activity at refrigeration temperatures (0°C), making them ideal for post-harvest storage. This combination of mechanisms provides robust protection against major post-harvest pathogens like Botrytis cinerea and Rhizopus stolonifer.

· As a Source of Immunomodulatory β-Glucans: The purified β-glucans from D. hansenii represent a valuable postbiotic for veterinary and potentially human applications. First, immune activation: They stimulate phagocytic activity and respiratory burst in leukocytes, enhancing the ability to eliminate pathogens. Second, antioxidant support: They increase superoxide dismutase and catalase activities, protecting cells from oxidative damage. Third, safety: They are non-toxic and do not induce aberrant inflammation. This makes D. hansenii-derived β-glucans a promising alternative to other yeast-derived immunostimulants, with potential applications in animal health and possibly human nutraceuticals.

· In Food Fermentation and Flavor Development: D. hansenii plays a crucial role in producing characteristic flavors in fermented foods. First, volatile compound generation: The yeast produces branched-chain aldehydes and alcohols associated with butter, caramel, cheese, and fruit aromas. Second, bioconversion activity: It shows high bioconversion activity from ferulic acid to 4-vinylguaiacol, a characteristic flavor compound of soybean products. Third, enzyme activities: Proteases and lipases hydrolyze proteins and lipids, releasing amino acids and fatty acids that serve as flavor precursors. This metabolic versatility contributes to the unique sensory profiles of artisanal cheeses, dry sausages, and soy sauces.

Safety and Toxicological Profile

Debaryomyces hansenii has a long history of safe use in food and has been granted Qualified Presumption of Safety status by the European Food Safety Authority. However, important safety considerations exist:

Clinical Infections: D. hansenii (referred to as Candida famata in clinical literature) is responsible for approximately 2% of candidiasis cases. This includes bloodstream infections, particularly in immunocompromised patients or those with indwelling medical devices. Some historical reports of pathogenicity may represent misidentification, but legitimate infections do occur. Therefore, while D. hansenii is safe for healthy individuals and animals, caution is warranted in immunocompromised populations.

Crohn's Disease Association: Research has suggested a potential link between D. hansenii and impaired wound healing in Crohn's disease. The yeast may be one of several fungal species that contribute to the pathogenesis of this inflammatory bowel disease in susceptible individuals. This does not preclude its use in healthy populations but suggests caution in those with inflammatory bowel conditions.

Acute Oral Toxicity: Comprehensive acute oral toxicity studies in animal models have confirmed the safety of D. hansenii isolates. No virulence or acute oral toxicity was observed for strains intended for probiotic use.

Quality Control: As a live microorganism, quality control is essential. Strain selection is critical, as different strains may have different safety and efficacy profiles. Viability, purity, and absence of contaminating pathogens must be verified for commercial products.

Conclusion: Debaryomyces hansenii is a remarkable yeast species that has transitioned from a background fermenter in traditional foods to a leading candidate for next-generation probiotics and biocontrol agents. Its extraordinary halotolerance and psychrotolerance, combined with a diverse arsenal of bioactive compounds β-glucans, polyamines, killer toxins, and cell wall-degrading enzymes enable it to function effectively in challenging environments. The rigorous validation of its probiotic effects through transcriptomics, histology, and functional assays in aquaculture represents a model for modern probiotic research. Its safety profile, supported by a long history of food use and formal Qualified Presumption of Safety status, makes it suitable for commercial development. As research continues to uncover new strains, mechanisms, and applications, D. hansenii is poised to play an increasingly important role in sustainable animal production, post-harvest preservation, and the development of functional foods.

---

Disclaimer:

Debaryomyces hansenii is generally recognized as safe based on its long history of use in food fermentation and its Qualified Presumption of Safety status. However, the yeast has been associated with rare cases of fungemia, particularly in immunocompromised individuals or those with indwelling catheters. Caution is warranted when considering therapeutic use in severely immunocompromised populations. The potential association with Crohn's disease suggests caution in individuals with inflammatory bowel conditions. As with all probiotics, quality-controlled products from reputable sources should be used. This information is for educational purposes only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· The Yeasts: A Taxonomic Study (5th Edition) by C.P. Kurtzman, J.W. Fell, and T. Boekhout

· Yeast Biotechnology: Diversity and Applications by T. Satyanarayana and G. Kunze

· Probiotics in Aquaculture by S.H. Hoseinifar and M. Yousefi

· Biology of Marine Fungi by C. Raghukumar

· Stress Tolerance in Yeasts by S. Hohmann and W.H. Mager

---

9. Further Study: Microorganisms That Might Interest You Due to Similar Medicinal Properties

1. Saccharomyces cerevisiae var. boulardii

· Species: Saccharomyces cerevisiae var. boulardii | Family: Saccharomycetaceae

· Similarities: The only yeast probiotic currently used extensively in human medicine. Both S. boulardii and D. hansenii share immunomodulatory properties through β-glucans and are used for gastrointestinal health. S. boulardii is more established for treating and preventing antibiotic-associated diarrhea, while D. hansenii shows promise in aquaculture and animal production.

2. Yarrowia lipolytica

· Species: Yarrowia lipolytica | Family: Dipodascaceae

· Similarities: Another non-conventional yeast used in food fermentation and biotechnology. Like D. hansenii, Y. lipolytica produces lipases and proteases that contribute to flavor development in cheese and other fermented products. It is also studied for its probiotic potential and ability to utilize hydrophobic substrates.

3. Lactobacillus rhamnosus GG

· Species: Lacticaseibacillus rhamnosus GG | Family: Lactobacillaceae

· Similarities: While a bacterium rather than a yeast, L. rhamnosus GG shares with D. hansenii a well-established probiotic profile, including gut microbiota modulation, immunostimulation, and safety. Both organisms have been extensively studied for their effects on intestinal health and disease prevention.

4. Akkermansia muciniphila

· Species: Akkermansia muciniphila | Family: Verrucomicrobiaceae

· Similarities: A next-generation probiotic bacterium that, like D. hansenii, is associated with gut barrier function and immunomodulation. Both microorganisms have been linked to metabolic health and are being investigated for their therapeutic potential in obesity and inflammatory conditions.

---

-x-x-x-End-x-x-x-